These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16272750)

  • 1. Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method.
    Harada S; Yamashita F; Hashida M
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):331-6. PubMed ID: 16272750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal administration of emedastine.
    Harada S; Takahashi Y; Nakagawa H
    Biol Pharm Bull; 1993 Sep; 16(9):884-8. PubMed ID: 7903575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vehicle properties on skin penetration of emedastine.
    Harada S; Takahashi Y; Nakagawa H; Yamashita F; Hashida M
    Biol Pharm Bull; 2000 Oct; 23(10):1224-8. PubMed ID: 11041256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical considerations on antihistamine effects of topically administered emedastine.
    Harada S; Nakada Y; Yamashita F; Hashida M
    J Pharm Sci; 2005 Jan; 94(1):17-24. PubMed ID: 15761926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro metabolism of an antiallergic agent, emedastine difumarate, in rats and guinea pigs].
    Wada Y; Hamada T; Kawashima T; Awata N
    Yakugaku Zasshi; 1990 Jan; 110(1):40-8. PubMed ID: 1972410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers.
    Brunner M; Kletter K; Assandri A; Ermanno Corrado M; Eichler HG; Müller M
    Xenobiotica; 2002 Sep; 32(9):761-70. PubMed ID: 12396273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.
    Yanni JM; Stephens DJ; Parnell DW; Spellman JM
    J Ocul Pharmacol; 1994; 10(4):665-75. PubMed ID: 7714410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.
    Joukhadar C; Herranz U; Pernerstorfer T; Assandri A; Klein N; Schrolnberger C; Lackner E; Eichler HG; Müller M
    Eur J Clin Pharmacol; 2001 Mar; 56(12):905-10. PubMed ID: 11317479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
    Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
    Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers.
    Jansen B; Graselli U; Dallinger S; Kiss B; Wacheck V; Schlagbauer-Wadl H; Assandri A; Müller M
    Eur J Clin Pharmacol; 2000; 55(11-12):837-41. PubMed ID: 10805062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous penetration and metabolism of 2-butoxyethanol.
    Lockley DJ; Howes D; Williams FM
    Arch Toxicol; 2004 Nov; 78(11):617-28. PubMed ID: 15455191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of emedastine difumarate on histamine release.
    Saito T; Hagihara A; Igarashi N; Matsuda N; Yamashita A; Ito K; Mio M; Tasaka K
    Jpn J Pharmacol; 1993 Jun; 62(2):137-43. PubMed ID: 7690432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion.
    Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E
    Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGA
    Tanida N; Akiyama K; Terahara T
    Nihon Yakurigaku Zasshi; 2018; 152(5):246-255. PubMed ID: 30393257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and ex vivo percutaneous absorption of [14C]-bisphenol A in rats: a possible extrapolation to human absorption?
    Marquet F; Payan JP; Beydon D; Wathier L; Grandclaude MC; Ferrari E
    Arch Toxicol; 2011 Sep; 85(9):1035-43. PubMed ID: 21287149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives.
    Taş C; Ozkan Y; Savaşer A; Baykara T
    Drug Dev Ind Pharm; 2004 Jul; 30(6):637-47. PubMed ID: 15285337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.
    Bando H; Sahashi M; Yamashita F; Takakura Y; Hashida M
    Pharm Res; 1997 Jan; 14(1):56-62. PubMed ID: 9034221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transport of an antiallergic agent, emedastine difumarate: interspecies difference in rats and guinea pigs.
    Sakai T; Awata N; Watanabe J
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1349-52. PubMed ID: 2393961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-octyl-beta-thioglucoside enhances the transdermal permeation of ketotifen.
    Murthy SN; Vishwanath BA
    Pharmazie; 2006 Jan; 61(1):75-6. PubMed ID: 16454213
    [No Abstract]   [Full Text] [Related]  

  • 20. Theoretical analysis of the effect of cutaneous metabolism on skin permeation of parabens based on a two-layer skin diffusion/metabolism model.
    Seko N; Bando H; Lim CW; Yamashita F; Hashida M
    Biol Pharm Bull; 1999 Mar; 22(3):281-7. PubMed ID: 10220285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.